Quest Diagnostics Inc

NYSE:DGXHealthcareCBOE:SPESGNASDAQ:NQUSMG

$234.90−0.04%At closeAt close · Mon 19 Oct · ≈ AED 862.67 · Market cap $25.93B · Next earnings Tue 20 Oct

DGX · Income statement · TradingHolo

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	9.4	10.8	9.9	9.3	9.9	11.0	11.6	+4.8%
Cost of revenue	5.8	6.6	6.5	6.2	6.6	7.5	7.7	+2.9%
Gross profit	3.6	4.2	3.4	3.1	3.2	3.5	3.7	+5.6%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	1.6	1.7	1.9	1.6	1.8	2.0	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	1.7	1.8	2.0	1.8	1.9	1.9	8.0	+315.5%
Operating income	2.0	2.4	1.4	1.3	1.3	1.6	1.6	+1.7%
Interest expense	0.2	0.2	0.1	0.2	0.2	0.3	0.2	−11.6%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other income / expense	(0.0)	0.3	(0.1)	(0.1)	(0.2)	(0.2)	—	—
Pre-tax income	2.0	2.7	1.3	1.2	1.2	1.4	1.4	+3.2%
Income tax	0.5	0.6	0.3	0.2	0.3	0.3	0.3	+1.9%
Net income	1.4	2.0	0.9	0.9	0.9	1.0	1.1	+7.1%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	10.68	15.90	8.12	7.59	7.80	8.87	9.54	+7.5%
EPS, diluted (per share)	10.52	15.53	7.98	7.52	7.69	8.75	9.43	+7.7%
EBITDA	2.4	3.2	1.8	1.7	1.9	2.2	2.1	−4.4%
Depreciation & amortization	0.4	0.4	0.4	0.4	0.5	0.6	0.5	−17.5%
Weighted average shares (shares)	134,000,000	125,000,000	116,000,000	112,000,000	111,000,000	111,000,000	—	—
Weighted average diluted shares (shares)	136,000,000	128,000,000	118,000,000	113,000,000	113,000,000	113,000,000	—	—
Gross margin	38.5%	39.0%	34.7%	33.2%	32.9%	31.9%	32.2%	+0.3 pts
Operating margin	20.9%	22.1%	14.4%	13.6%	13.6%	14.5%	14.1%	−0.4 pts
Net margin	15.2%	18.5%	9.6%	9.2%	8.8%	9.0%	9.2%	+0.2 pts

USD billionsUpdated Thu 23 Jul ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.